Thaçi, Diamant, April Armstrong, Kenneth B Gordon, Andrew Blauvelt, Carl Paul, Wolf-Henning Boehncke, Maggie Wang, Balint Szilagyi, Bengt Hoepken, Jeremy Lambert, and Mark Lebwohl. 2024. “Bimekizumab 3-Year Maintenance of Response in Week 16 Responders With Moderate to Severe Plaque Psoriasis: Results from Five Phase 3/3b Trials”. SKIN The Journal of Cutaneous Medicine 8 (1):s306.